Matrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior

Simple item page
dc.citation.firstpage64
dc.citation.journalTitleMatrix Biology
dc.citation.lastpage76
dc.citation.volumeNumber36
dc.contributor.authorGrindel, B.J.
dc.contributor.authorMartinez, J.R.
dc.contributor.authorPennington, C.L.
dc.contributor.authorMuldoon, M.
dc.contributor.authorStave, J.
dc.contributor.authorChung, L.W.
dc.contributor.authorFarach-Carson, Mary C.
dc.contributor.orgShared Equipment Authority
dc.date.accessioned2014-10-09T15:38:26Z
dc.date.available2014-10-09T15:38:26Z
dc.date.issued2014
dc.description.abstractPerlecan/HSPG2, a large heparan sulfate (HS) proteoglycan, normally is expressed in the basement membrane (BM) underlying epithelial and endothelial cells. During prostate cancer (PCa) cell invasion, a variety of proteolytic enzymes are expressed that digest BM components including perlecan. An enzyme upregulated in invasive PCa cells, matrilysin/matrix metalloproteinase-7 (MMP-7), was examined as a candidate for perlecan proteolysis both in silico and in vitro. Purified perlecan showed high sensitivity to MMP-7 digestion even when fully decorated with HS or when presented in native context connected with other BM proteins. In both conditions, MMP-7 produced discrete perlecan fragments corresponding to an origin in immunoglobulin (Ig) repeat region domain IV. While not predicted by in silico analysis, MMP-7 cleaved every subpart of recombinantly generated perlecan domain IV. Other enzymes relevant to PCa that were tested had limited ability to cleave perlecan including prostate specific antigen, hepsin, or fibroblast activation protein α. A long C-terminal portion of perlecan domain IV, Dm IV-3, induced a strong clustering phenotype in the metastatic PCa cell lines, PC-3 and C4-2. MMP-7 digestion of Dm IV-3 reverses the clustering effect into one favoring cell dispersion. In a C4-2 Transwell® invasion assay, perlecan-rich human BM extract that was pre-digested with MMP-7 showed loss of barrier function and permitted a greater level of cell penetration than untreated BM extract. We conclude that enzymatic processing of perlecan in the BM or territorial matrix by MMP-7 as occurs in the invasive tumor microenvironment acts as a molecular switch to alter PCa cell behavior and favor cell dispersion and invasiveness.
dc.identifier.citationGrindel, B.J., Martinez, J.R., Pennington, C.L., et al.. "Matrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior." <i>Matrix Biology,</i> 36, (2014) Elsevier: 64-76. http://dx.doi.org/10.1016/j.matbio.2014.04.005.
dc.identifier.doihttp://dx.doi.org/10.1016/j.matbio.2014.04.005
dc.identifier.urihttps://hdl.handle.net/1911/77506
dc.language.isoeng
dc.publisherElsevier
dc.rightsThis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/3.0/
dc.subject.keywordperlecan/HSPG2
dc.subject.keywordprostate cancer
dc.subject.keywordmatrix metalloproteinase-7/MMP7
dc.subject.keywordmatrilysin
dc.titleMatrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior
dc.typeJournal article
dc.type.dcmiText
dc.type.publicationpublisher version
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
MMP7.pdf
Size:
2.38 MB
Format:
Adobe Portable Document Format
Download
Collections
Faculty Publications
Biochemistry and Cell Biology Publications
Bioengineering Publications